Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials.
Jennifer L LundJenna CacciatoreRachael G TylockI-Hsuan SuSaloni SharmaSharon Peacock HintonSabirah SmithMolly A NowelsXiaomeng Chen MsphPaul R DubersteinLaura C HansonSupriya G MohilePublished in: JCO clinical cancer informatics (2024)
Extending clinical trial mortality follow-up through linkage with external data sources was feasible and accurate. Future cancer clinical trials should collect necessary consent and patient identifiers for vital status linkages that can enhance understanding of longer-term outcomes.
Keyphrases
- clinical trial
- advanced cancer
- palliative care
- cardiovascular events
- phase ii
- papillary thyroid
- risk factors
- open label
- physical activity
- electronic health record
- preterm infants
- study protocol
- high resolution
- phase iii
- genome wide
- squamous cell
- metabolic syndrome
- current status
- double blind
- community dwelling
- big data
- randomized controlled trial
- mass spectrometry
- weight loss
- machine learning
- squamous cell carcinoma
- insulin resistance
- dna methylation
- deep learning
- artificial intelligence
- glycemic control